Formulary considerations for treating psychiatric disorders: Schizophrenia.
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 142
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 1997 AND VI 32 AND IP 2
Results: 9
1
2
New drug and biologic approvals.
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 176
- Publication type:
- Article
3
Top drugs of 1996.
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 175
- Publication type:
- Article
4
Meeting highlights.
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 169
- Publication type:
- Article
5
How to calculate the costs of drug preparation, delivery, and administration.
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 156
- By:
- Publication type:
- Article
6
FDA ponders Internet regs, encourages more supplemental NDAs to cool off-label debate.
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 184
- By:
- Publication type:
- Article
7
Focus on acitretin: An aromatic retinoid approved for the treatment of severe recalcitrant...
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 125
- By:
- Publication type:
- Article
8
News capsules.
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 120
- Publication type:
- Article
9
FDA news and product notes.
- Published in:
- Formulary, 1997, v. 32, n. 2, p. 111
- Publication type:
- Article